4//SEC Filing
Bellemin Jean-Marc 4
Accession 0001104659-25-021866
CIK 0001425205other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:05 PM ET
Size
6.2 KB
Accession
0001104659-25-021866
Insider Transaction Report
Form 4
Bellemin Jean-Marc
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2025-03-05+93,750→ 93,750 total→ Common stock (93,750 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001754253
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 8:05 PM ET
- Size
- 6.2 KB